|
Delayed
NSE India S.E.
07:05:07 2026-09-17 am EDT
|
5-day change | 1st Jan Change | ||
| 1,376.30 INR | +1.35% |
|
+0.22% | -8.93% |
| Sep. 03 | India's Cipla, China's Qilu partner for US launch of Merck's Keytruda biosimilar | RE |
| Aug. 25 | Cipla's Pithampur, India Unit Gets 7 Observations From US FDA | MT |
Company Valuation: Cipla Limited
Data adjusted to current consolidation scope
| Fiscal Period: March | 2022 | 2023 | 2024 | 2025 | 2026 | 2027 | 2028 | 2029 |
|---|---|---|---|---|---|---|---|---|
| Market Cap 1 | 821,377 | 726,839 | 1,208,588 | 1,164,745 | 988,887 | 1,097,060 | - | - |
| Change | - | -11.51% | 66.28% | -3.63% | -15.1% | 10.94% | - | - |
| Enterprise Value (EV) 1 | 810,334 | 716,397 | 1,154,239 | 1,084,736 | 901,599 | 990,987 | 965,616 | 949,224 |
| Change | - | -11.59% | 61.12% | -6.02% | -16.88% | 9.91% | -2.56% | -1.7% |
| P/E | 32.7x | 26x | 29.3x | 22.1x | 25.5x | 26.4x | 21.3x | 18.9x |
| PBR | 3.94x | 3.11x | 4.53x | 3.73x | 2.87x | 2.92x | 2.65x | 2.39x |
| PEG | - | 2.3x | 0.6x | 0.8x | -1x | 3.76x | 0.9x | 1.5x |
| Capitalization / Revenue | 3.77x | 3.19x | 4.69x | 4.23x | 3.51x | 3.54x | 3.16x | 2.89x |
| EV / Revenue | 3.72x | 3.15x | 4.48x | 3.94x | 3.2x | 3.2x | 2.78x | 2.5x |
| EV / EBITDA | 17.8x | 14.3x | 18.3x | 15.2x | 15.3x | 16.6x | 13.1x | 11.5x |
| EV / EBIT | 23.1x | 18.6x | 22x | 18x | 19.3x | 21.3x | 16.2x | 13.9x |
| EV / FCF | 29.1x | 29.9x | 38x | 28.2x | 38.5x | 34.9x | 26.8x | 23.8x |
| FCF Yield | 3.43% | 3.35% | 2.63% | 3.54% | 2.6% | 2.86% | 3.73% | 4.2% |
| Dividend per Share 2 | 5 | 8.5 | 13 | 13 | 13 | 12.99 | 14.73 | 14.28 |
| Rate of return | 0.49% | 0.94% | 0.87% | 0.9% | 1.06% | 0.96% | 1.08% | 1.05% |
| EPS 2 | 31.17 | 34.69 | 51.01 | 65.24 | 48 | 51.37 | 63.72 | 72.01 |
| Distribution rate | 16% | 24.5% | 25.5% | 19.9% | 27.1% | 25.3% | 23.1% | 19.8% |
| Net sales 1 | 217,633 | 227,531 | 257,741 | 275,476 | 281,626 | 309,885 | 347,303 | 379,577 |
| EBITDA 1 | 45,528 | 50,270 | 62,910 | 71,279 | 58,829 | 59,815 | 73,606 | 82,600 |
| EBIT 1 | 35,008 | 38,549 | 52,400 | 60,210 | 46,719 | 46,616 | 59,576 | 68,357 |
| Net income 1 | 25,168 | 28,019 | 41,216 | 52,725 | 38,792 | 41,355 | 51,415 | 58,114 |
| Net Debt 1 | -11,043 | -10,443 | -54,350 | -80,010 | -87,289 | -106,073 | -131,444 | -147,836 |
| Reference price 2 | 1,018.05 | 900.50 | 1,496.95 | 1,442.20 | 1,224.20 | 1,358.00 | 1,358.00 | 1,358.00 |
| Nbr of stocks (in thousands) | 806,814 | 807,151 | 807,367 | 807,617 | 807,783 | 807,850 | - | - |
| Announcement Date | 5/10/22 | 5/12/23 | 5/10/24 | 5/13/25 | 5/13/26 | - | - | - |
1INR in Million2INR
Estimates
P/E, Detailed evolution
| P/E (N) | EV / Sales (N) | EV / EBITDA (N) | Dividend Yield (N) | Capi.($) | ||
|---|---|---|---|---|---|---|
 | 26.44x | 3.2x | 16.57x | 0.96% | 11.44B | |
| 34.2x | 6.42x | 22.23x | 0.92% | 46.36B | |
| 15.64x | 1.93x | 8.56x | 1.69% | 36.94B | |
| 26.55x | 3.8x | 15.76x | 0.61% | 11.52B | |
| 18.76x | 3.41x | 11.87x | 3.75% | 9.17B | |
| 9.27x | 2.14x | 5.54x | 4.79% | 7.27B | |
| 14.8x | 1.95x | 6.47x | 3.36% | 7.06B | |
| 29.31x | 3.83x | 17.83x | 0.16% | 7.09B | |
| 35x | 6.82x | 24.95x | 0.99% | 4.57B | |
| Average | 23.33x | 3.72x | 14.42x | 1.92% | 15.71B | |
| Weighted average by Cap. | 24.63x | 4.01x | 15.22x | 1.57% |
Y-o-Y evolution of P/E
Historical PBR trend
Evolution Enterprise Value / Sales
Change in Enterprise Value/EBITDA
Year-on-year evolution of the Yield
- Stock Market
- Stocks
- CIPLA Stock
- Valuation Cipla Limited
Select your edition
All financial news and data tailored to specific country editions
